<SEC-DOCUMENT>0001193125-18-171458-index.html : 20180523
<SEC-HEADER>0001193125-18-171458.hdr.sgml : 20180523
<ACCEPTANCE-DATETIME>20180523083132
ACCESSION NUMBER:		0001193125-18-171458
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180331
FILED AS OF DATE:		20180523
DATE AS OF CHANGE:		20180523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-80623
		FILM NUMBER:		18854126

	BUSINESS ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<FILENAME>d587186d10qa.htm
<DESCRIPTION>FORM 10-Q AMENDMENT NO. 1
<TEXT>
Document 1 - file: d587186d10qa.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d587186dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
Document 2 - file: d587186dex101.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>d587186dex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
Document 3 - file: d587186dex311.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>d587186dex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
Document 4 - file: d587186dex312.htm

</DOCUMENT>
</SEC-DOCUMENT>